Abstract:BACKGROUND: The DYNC1H1 gene encodes a part of the dynamic protein, and the protein mutations may further affect the growth and development of neurons, resulting in degeneration of anterior horn cells of the spinal cord, and a variety of clinical phenotypes finally resulting in axonal Charcot-Marie-Tooth disease type 20 (CMT20), mental retardation 13 (MRD13) and spinal muscular atrophy with lower extremity predominant 1 (SMA-LED). The incidence of the disease is low, and it is difficult to diagnose, especially in children. Here, we report a case of DYNC1H1 gene mutation and review the related literature to improve the pediatrician's understanding of DYNC1H1 gene-related disease to make an early correct diagnosis and provide better services for children.CASE SUMMARY: A 4-mo-old Chinese female child with adducted thumbs, high arch feet, and epileptic seizure presented slow response, delayed development, and low limb muscle strength. Electroencephalogram showed abnormal waves, a large number of multifocal sharp waves, sharp slow waves, and multiple spasms with a series of attacks. High-throughput sequencing and Sanger sequencing identified a heterozygous mutation, c.5885G>A (p.R1962H), in the DYNC1H1 gene (NM_001376) of the proband, which was not identified in her parents. Combined with the clinical manifestations and pedigree of this family, this mutation is likely pathogenic based on the American Academy of Medical Genetics and Genomics guidelines. The child was followed when she was 1 year and 2 mo old. The magnetic resonance imaging result was consistent with the findings of white matter myelinated dysplasia and congenital giant gyrus. The extensive neurogenic damage to the extremities was considered, as the results of electromyography showed that the motor conduction velocity and sensory conduction of the nerves of the extremities were not abnormal, and the degree of fit of the children with severe contraction was poor. At present, the child is 80 cm in length and 9 kg in weight, with slender limbs and low muscle strength, and still does not raise her head. She cannot sit or speak. Speech, motor, and mental development was significantly delayed. There is still no effective treatment for this disease.CONCLUSION: We herein report a de novo variant of DYNC1H1 gene, c.5885G>A (p.R1962H), leading to overlapping phenotypes (seizure, general growth retardation, and muscle weakness) of CMT20, MRD13, and SMA-LED, but there is no effective treatment for such condition. Our case enriches the DYNC1H1 gene mutation spectrum and provides an important basis for clinical diagnosis and treatment and genetic counseling.

Defective DcpS Decapping Manifests in Creatine Deficiency Syndrome and Neurological impairment

Long-term Follow-Up of Children with Carbamoyl Phosphate Synthase 1 Deficiency Detected in Newborn Screening.

Fourteen Cases of Cerebral Creatine Deficiency Syndrome in Children: a Cohort Study in China.

Cerebellar Defects in Pdss2 Conditional Knockout Mice During Embryonic Development and in Adulthood

Biochemical, molecular, and clinical diagnoses of patients with cerebral creatine deficiency syndromes.

<i>Ccdc134</i> deficiency impairs cerebellar development and motor coordination

[Genetic Analysis and Treatment for an Infant with Cerebral Creatine Deficiency Syndrome Type 2].

Response to therapy of creatine transporter deficiency caused by a hypomorphic variant in SLC6A8

[Clinical Features and SLC6A8 Gene Mutations of Cerebral Creatine Deficiency Syndrome I: an Analysis of Two Families].

Deletion of Brain Dystroglycan Recapitulates Aspects of Congenital Muscular Dystrophy

Creatine Transporter Deficiency Presenting as Failure to Thrive: A Case Report of a Novel SLC6A8 Variant Causing a Treatable but Likely Underdiagnosed Genetic Disorder

Lack of GDAP1 Induces Neuronal Calcium and Mitochondrial Defects in a Knockout Mouse Model of Charcot-Marie-Tooth Neuropathy

Epigenetic alterations in creatine transporter deficiency: a new marker for dodecyl creatine ester therapeutic efficacy monitoring

[Clinical and Genetic Analysis of a Child with Cerebral Creatine Deficiency Syndrome Due to Variant of SLC6A8 Gene].

Connectomic and behavioral alterations in creatine transporter deficiency are partially normalized by gene therapy

Missense mutation in DYNC1H1 gene caused psychomotor developmental delay and muscle weakness: A case report

The Metabolite Saccharopine Impairs Neuronal Development by Inhibiting the Neurotrophic Function of Glucose-6-Phosphate Isomerase

CSMD3 Deficiency Leads to Motor Impairments and Autism-Like Behaviors Via Dysfunction of Cerebellar Purkinje Cells in Mice.

Gain-of-Function KIDINS220 Variants Disrupt Neuronal Development and Cause Cerebral Palsy

Creatine transporter deficiency impairs stress adaptation and brain energetics homeostasis

Unraveling cardiomyocyte responses and intercellular communication alterations in primary carnitine deficiency cardiomyopathy via single-nucleus RNA sequencing